Bryan T Reuther, PSYD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 3209 Virginia Ave, Fort Pierce, FL 34981 Phone: 772-462-7981 |
Martha Ann Oates Psychologist - Mental Retardation & Developmental Disabilities Medicare: Not Enrolled in Medicare Practice Location: 2519 Avenue L, Fort Pierce, FL 34947 Phone: 772-925-4636 |
Brenda S Bennett Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 2011 S 25th St Ste 108, Fort Pierce, FL 34947 Phone: 772-242-1079 Fax: 772-242-1296 |
Miss Diana Isabel D'anglada, MA Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 2814 S Us Highway 1 Ste D4, Fort Pierce, FL 34982 Phone: 787-489-4726 |
Dr. Rhaina A Smeds, PSYD Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 100 Avenue A Ste 2d, Fort Pierce, FL 34950 Phone: 772-485-4008 Fax: 772-334-0225 |
News Archive
Diabetes is a chronic disease that occurs when the pancreas does not produce enough insulin - a hormone that regulates blood sugar - or the body cannot effectively use the insulin it produces. According to the Diabetes Research Institute Foundation, the disease is increasing at an alarming rate in the United States, with an estimated 30.3 million people currently with diabetes.
Wayne State University recently entered into an exclusive license agreement with TRImaran Pharma Inc. for a class of novel drugs developed at Wayne State University that aims to offer hope in the treatment of post-traumatic stress disorders (PTSD), depression, ADHD and other neurological disorders.
Long before symptoms of Alzheimer's disease become apparent to patients and their families, biological changes are occurring within the brain. Amyloid plaques, which are clusters of protein fragments, along with tangles of protein known as tau, form in the brain and grow in number, eventually getting in the way of the brain's ability to function.
Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., today announced the U.S. commercial availability of CUVPOSA™ (glycopyrrolate) oral solution, the first and only FDA-approved treatment to reduce chronic severe drooling in patients aged 3 to 16 with neurologic conditions associated with problem drooling, such as cerebral palsy.
After a week of stepped-up health reform activity, today's headlines highlight that the White House is intensifying its final push by setting a deadline for congressional action. Meanwhile, though, the Democratic party continues to face rifts within its own caucus. Abortion coverage issues again posing challenges to securing Democratic votes.
› Verified 9 days ago